2 ms·
Obviously you can't give all Alzheimer's patients your experimental drug/treatment that isn't even shown to work yet. That would not make any sense, and would n
by jrochkind1 7y ago
Obviously you can't give all Alzheimer's patients your experimental drug/treatment that isn't even shown to work yet. That would not make any sense, and would not in fact be ethical.
So, yeah, that is how controls work, generally. If there is some other standardly accepted treatment for Alzheimer's already, it might be unethical to _refrain_ from giving that, perhaps the control would be given that too. But it's not unethical not to give someone the treatment that you don't even know if it works yet.
Usually. As a general principle. These are certainly interesting things to talk about in the field of medical ethics, and you can find lots of discussion of them in article and such, it's not always totally straightforward or universally agreed upon and of course medical researchers do unethical things all the time.
But simply having a control group that does not get the treatment you are researching is not by itself considered unethical. Which seems to be what you are suggesting. Remember that you don't know if the experimental treatment works at all, that's why it's being studied -- it may even make the condition _worse_, or have negative side effects.
And yes, having a control group is normal procedure. And that's what a control group is, starting off in the same place as the experimental group, but not receiving the experimental treatment, with other conditions being normalized the same. If the control group is 'double blinded', then neither the subjects nor the research staff know if a given subject is receiving the experimental treatment or control.